Subscribe to Newsletter

Content by Roisin McGuigan:

 Manufacture Small Molecules

Ancient Herbs with Modern Promise?

| Roisin McGuigan

A new collaboration aims to put ancient Chinese ingredients to the test.
Business & Regulation Business Practice

First in Class

| Roisin McGuigan

Pharma steals the two top spots in a ranking of the best online corporate communications.
Business & Regulation Business Practice

Calling Time on Bad Behavior

| Roisin McGuigan

The pharma industry is no stranger to sexual harassment, but companies are now taking a more public stance on the matter.
Manufacture Analytical Science

Think Fast, Screen Faster

| Roisin McGuigan

Ten thousand reactions per hour – or else? No problem!
Business & Regulation Business Practice

A Problem Shared…

| Roisin McGuigan

It’s time for pharma to join the crowdsourcing revolution.
Discovery & Development Clinical Trials

Cherchez la Femme?

| Roisin McGuigan

A review of FDA data suggests that women are now better represented in clinical trials.
Business & Regulation Business Practice

What’s in a (Brand) Name?

| Roisin McGuigan

Do patients care about your brand? Not as much as they care about your outcomes.
Manufacture Business Practice

Business-in-Brief

| Roisin McGuigan

Bribery investigations, sitting out the Super Bowl, and achieving excellence online…
Manufacture Business Practice

From Strength to Strength

| Roisin McGuigan

Sitting Down With… Nigel Darby, Advisor, GE Healthcare Life Sciences, Sweden.
Register to The Medicine Maker

Register to access our FREE online portfolio, request the magazine in print and manage your preferences.

You will benefit from:
  • Unlimited access to ALL articles
  • News, interviews & opinions from leading industry experts
  • Receive print (and PDF) copies of The Medicine Maker magazine

Register

April Issue of The Medicine Maker